本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
RiverVest Venture Management LLC (CIK 1812549) reported $6.8M across 3 reported positions in its SEC 13F filing for 2024-09-30. Largest positions: OKUR ($4.3M, 63.00%), SPRB ($1.4M, 20.39%), XLO ($1.1M, 16.60%), VAPO ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | OKUR | Reneo Pharmaceuticals, Inc. | $4.3M | 63.00% | 2.5M | Hold |
| 2 | SPRB | Spruce Bioscience, Inc. | $1.4M | 20.39% | 2.9M | Hold |
| 3 | XLO | Xilio Therapeutics, Inc. | $1.1M | 16.60% | 1.4M | Hold |
| 4 | VAPO | Vapotherm, Inc. | $0 | 0.00% | 0 | Exited |
来源：SEC 13F 申报文件 · 截至 2024-09-30